Both in Pharmaceuticals
Longeveron vs CNS Pharmaceuticals
Over the past year LGVN returned −81.2% and CNSP returned −47.2%; their daily moves had a correlation of -0.01.
LGVN −81.2% CNSP −47.2%Growth of $1, one year, split-adjusted
| Metric | LGVN | CNSP |
|---|---|---|
| Price | $1.56 | $4.53 |
| Market cap | $5.0M | $6.6M |
| Today | −2.20% | −4.63% |
| 1 month | −46.6% | −12.0% |
| 6 months | −83.5% | +92.8% |
| Year to date | −69.3% | −13.7% |
| 1 year | −81.2% | — |
| Revenue growth (YoY) | −9.2% | — |
| Gross margin | 63.4% | — |
| Net margin | −2116.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.2× | — |
| Net cash | $10.1M | $20.0M |
| Dividend yield | — | — |
| Volatility (60d) | 708.7% | 70.7% |
| Short % of float | 4.1% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).